Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000824378 | SCV000965274 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-12-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381885 | SCV002674491 | uncertain significance | Cardiovascular phenotype | 2024-06-17 | criteria provided, single submitter | clinical testing | The c.7423G>A (p.V2475I) alteration is located in exon 45 (coding exon 45) of the FLNC gene. This alteration results from a G to A substitution at nucleotide position 7423, causing the valine (V) at amino acid position 2475 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003489919 | SCV004234825 | uncertain significance | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005036230 | SCV005672934 | uncertain significance | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26 | 2024-06-10 | criteria provided, single submitter | clinical testing |